Senior insider sale
Chief Financial Officer at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$3.85M
46.90K shares
What this filing means
GORDON STEPHEN plans to sell 46.90K shares of TRANSMEDICS GROUP, INC. valued at approximately $3.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/18/2024ACC: 0000950170-24-032817
Officer· Chief Financial Officer
Since May 2019
46.90K
Shares to sell
$3.85M
Approx. market value
1.90K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units - See Remarks
Equity Compensation
3/8/2024
1.90KTotal acquired1.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/8/2024 | Vesting of Restricted Stock Units - See Remarks Equity Compensation | 1.90K | — |
| Total | 1.90K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
15K
Market value
$1.24M
3/4/2024
—Completed
Units to sell
15K
Market value
$1.28M
2/1/2024
—Completed
Units to sell
15K
Market value
$1.16M
1/2/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.90K
Market value
$166.8K
3/8/2024
Total
Units
46.90K
Value
$3.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2024 | 15K | $1.24M | — | Completed |
2/1/2024 | 15K | $1.28M | — | Completed |
1/2/2024 | 15K | $1.16M | — | Completed |
| Planned — Approximate Date | ||||
3/8/2024 | 1.90K | $166.8K | Nasdaq | Planned |
| Total | 46.90K | $3.85M | ||